CRLBF vs Peers Stock Comparison

Cresco Labs Prices as of Oct 26, 2026 Peers: Industry group
CRLBF Cresco Labs Inc.
$0.64 -14.7% 1M -47.5% 1Y
Market cap
$227.20M
P/E
–
Revenue (TTM)
$651.13M
Div. yield
–
Cannabis Consumer Staples

Percentile Scorecard

CRLBF

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCRLBF
Valuation 73 #11 of 38
Growth 9 #32 of 35
Profitability 51 #18 of 36
Financial Health 16 #33 of 39
Shareholder Returns –
Overall 37
  • CRLBF ranked among 40 companies in Tobacco and Cannabis

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCRLBFSPY
1 month -14.7% -0.8%
3 months -5.9% +3.5%
6 months -46.2% +7.0%
Year to date -48.0% +12.2%
1 year -47.5% +13.0%
3 years -44.8% +86.3%
3 years, per year -18.0% +23.1%
5 years -91.6% +68.6%
5 years, per year -39.1% +11.0%

Risk

MeasureCRLBFSPY
Volatility, 1Y 122.9% 12.7%
Downside volatility, 1Y 112.3% 12.7%
Beta vs S&P 500, 1Y 1.51 1.00
Return / volatility, 1Y -0.39 1.02
Max drawdown, 5Y -95.5% -25.4%
From 52-week high -66.7% -1.8%
52-week high $1.92 $779.14
52-week low $0.59 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCRLBF
P/E now vs peer median -2.2xmedian 16.5x
P/S now vs peer median 0.3xmedian 0.9x
EV/EBITDA now vs peer median 35.1xmedian 12.3x
P/FCF now vs peer median 36.4xmedian 23.1x
P/B now vs peer median 0.9xmedian 1.0x
PEG now vs peer median -0.07median 0.56

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCRLBF
Revenue $651.13M
Gross profit $325.08M
Operating income -$33.18M
Net income -$112.56M
Free cash flow $6.24M
EPS (diluted) $-0.30
Cash & equivalents $32.87M
Total debt $1.76B
Shares (diluted) 355.01M
Enterprise value -$36.67M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCRLBF
P/E -2.2x
P/FCF 36.4x
P/Operating cash flow 5.2x
P/S 0.3x
P/B 0.9x
P/Tangible book -3.9x
EV/EBITDA 35.1x
EV/EBIT -18.8x
EV/Revenue 1.0x
EV/FCF 100.3x
EV/Operating cash flow 14.4x
PEG (3Y EPS CAGR) -0.07

Growth

14 metrics
MetricCRLBF
Revenue growth (1Y) -5.0%
Revenue CAGR (3Y) -6.7%
Gross profit growth (1Y) -4.2%
Gross profit CAGR (3Y) -3.3%
Operating income growth (1Y) -144.0%
Operating income CAGR (3Y) 37.3%
Net income growth (1Y) -123.6%
Net income CAGR (3Y) 23.9%
EPS growth (1Y) -150.2%
EPS CAGR (3Y) 29.6%
Operating cash flow growth (1Y) -63.3%
Operating cash flow CAGR (3Y) 2.6%
Free cash flow growth (1Y) -95.7%
Free cash flow CAGR (3Y) -62.6%

Profitability

14 metrics
MetricCRLBF
Gross margin 49.9%
EBITDA margin 2.7%
Operating margin -5.1%
Pretax margin -15.9%
Net margin -16.1%
FCF margin 1.0%
Operating cash flow margin 6.7%
Return on equity -59.3%
Return on assets -12.2%
Return on invested capital -4.4%
Return on capital employed -3.0%
Asset turnover 0.5x
Cash conversion (OCF / net income) -0.4x
Stock comp / revenue 2.3%

Financial Health

11 metrics
MetricCRLBF
Debt / assets 34.1%
Debt / equity 1.6x
Net debt / EBITDA 22.4x
Debt / FCF 69.1x
Liabilities / assets 79.2%
Equity / assets 20.8%
Interest coverage –
Current ratio 1.8x
Quick ratio 0.5x
Cash ratio 0.2x
Altman Z-score -0.99

Shareholder Returns

7 metrics
MetricCRLBF
Dividend yield –
Net buyback yield –
Shareholder yield –
Payout ratio (earnings) –
Payout ratio (FCF) –
Dividend growth (1Y) –
Dividend CAGR (3Y) –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCRLBF
EPS, next fiscal year $-0.03FY2026
Revenue, next fiscal year $637.07MFY2026
Revenue growth, next FY -2.9%FY2026
Revenue growth, the year after +3.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCRLBF
Held by institutions 0.0%
Institutions holding 6
Change in shares held, QoQ -17.9%
Institutions buying 2
Institutions selling 0
Buyers to sellers –

Add a Peer

Largest companies in the same industry

Related Comparisons

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.